Aegirbio AB
F:52Q
Income Statement
Earnings Waterfall
Aegirbio AB
Income Statement
Aegirbio AB
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
0
N/A
|
0
+100%
|
7
+23 543%
|
12
+79%
|
13
+12%
|
15
+10%
|
8
-45%
|
3
-61%
|
2
-45%
|
0
-78%
|
0
+0%
|
0
-73%
|
0
-7%
|
0
-61%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
0
|
0
|
(4)
|
(7)
|
(8)
|
(9)
|
(5)
|
(2)
|
(25)
|
(25)
|
(25)
|
(24)
|
(0)
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
3
+20 607%
|
4
+53%
|
6
+24%
|
6
+10%
|
3
-48%
|
2
-51%
|
(24)
N/A
|
(24)
-3%
|
(24)
+0%
|
(24)
+0%
|
0
N/A
|
0
+191%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(19)
|
(38)
|
(60)
|
(80)
|
(86)
|
(100)
|
(92)
|
(84)
|
(65)
|
(342)
|
(338)
|
(341)
|
(56)
|
(50)
|
|
| Selling, General & Administrative |
(8)
|
(13)
|
(24)
|
(32)
|
(36)
|
(43)
|
(42)
|
(40)
|
(28)
|
(28)
|
(25)
|
(20)
|
(18)
|
(11)
|
|
| Research & Development |
(11)
|
(18)
|
(34)
|
(48)
|
(51)
|
(59)
|
(53)
|
(49)
|
(39)
|
(41)
|
(40)
|
(46)
|
(42)
|
(45)
|
|
| Other Operating Expenses |
0
|
(6)
|
(2)
|
(0)
|
1
|
1
|
3
|
5
|
3
|
(274)
|
(274)
|
(275)
|
4
|
6
|
|
| Operating Income |
(19)
N/A
|
(37)
-102%
|
(57)
-52%
|
(75)
-32%
|
(80)
-6%
|
(94)
-18%
|
(89)
+6%
|
(82)
+8%
|
(88)
-8%
|
(367)
-315%
|
(363)
+1%
|
(365)
-1%
|
(56)
+85%
|
(50)
+11%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(1)
|
(4)
|
(4)
|
(13)
|
(12)
|
(8)
|
1
|
1
|
(1)
|
(3)
|
(5)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(277)
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Pre-Tax Income |
(19)
N/A
|
(37)
-102%
|
(58)
-54%
|
(80)
-38%
|
(93)
-16%
|
(107)
-15%
|
(101)
+6%
|
(90)
+11%
|
(364)
-306%
|
(366)
0%
|
(364)
+0%
|
(368)
-1%
|
(61)
+83%
|
(51)
+17%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Income from Continuing Operations |
(19)
|
(37)
|
(58)
|
(80)
|
(92)
|
(107)
|
(100)
|
(88)
|
(363)
|
(364)
|
(363)
|
(367)
|
(60)
|
(49)
|
|
| Net Income (Common) |
(19)
N/A
|
(37)
-102%
|
(58)
-54%
|
(80)
-38%
|
(92)
-16%
|
(107)
-15%
|
(100)
+7%
|
(88)
+11%
|
(363)
-311%
|
(364)
0%
|
(363)
+0%
|
(367)
-1%
|
(60)
+84%
|
(49)
+17%
|
|
| EPS (Diluted) |
-1.42
N/A
|
-2.84
-100%
|
-3.71
-31%
|
-5.14
-39%
|
-5.64
-10%
|
-5.64
N/A
|
-3.4
+40%
|
-4.21
-24%
|
-18.9
-349%
|
-13.65
+28%
|
-15.18
-11%
|
-19.43
-28%
|
-2.38
+88%
|
-1.62
+32%
|
|